| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Mechanistic Study to Assess Whether Isoproterenol Can Reverse the Negative Chronotropic Effect of Fingolimod
|
Kovarik, John M.
|
|
2008
|
48 |
3 |
p. 303-310
|
artikel
|
| 2 |
BookReview: Burzykowoski T, Molenberghs G, Buyse M (Eds.). The Evaluation of Surrogate End Points. New York: Springer; 2005; XXIV; 416 pp.; $ 84.95
|
Kshirsagar, N.A.
|
|
2008
|
48 |
3 |
p. 390-391
|
artikel
|
| 3 |
BookReview: Day S. Dictionary for Clinical Trials, 2nd ed. New York: John Wiley & Sons; 2007; 262 pp.; $45.00 paperback, $130.00 hardback
|
|
|
2008
|
48 |
3 |
p. 391-391
|
artikel
|
| 4 |
BookReview: Kallen A. Computational Pharmacokinetics. Boca Raton, FL: Chapman & Hall/CRC Press; 2007; 170 pp.; $79.95
|
|
|
2008
|
48 |
3 |
p. 391-391
|
artikel
|
| 5 |
Books Available for Review
|
|
|
2008
|
48 |
3 |
p. 391-391
|
artikel
|
| 6 |
Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
|
Kalliokoski, Annikka
|
|
2008
|
48 |
3 |
p. 311-321
|
artikel
|
| 7 |
Effect of Itraconazole on the Pharmacokinetics of Imidafenacin in Healthy Subjects
|
Ohno, Tomoya
|
|
2008
|
48 |
3 |
p. 330-334
|
artikel
|
| 8 |
European Medicines Agency (EMEA), Committee for Medicinal Products for Human Use (CHMP). Guideline on the Reporting the Results of Population Pharmacokinetic Analyses. 21 June 2007. (http://www.emea.europa.eu/pdfs/ human/ewp/18599006enfin.pdf)
|
|
|
2008
|
48 |
3 |
p. 389-390
|
artikel
|
| 9 |
From the Editor
|
von Moltke, Lisa L.
|
|
2008
|
48 |
3 |
p. 266-266
|
artikel
|
| 10 |
Gui C-H, Li H, Levons J, Lentz K, Gandhi RB, Raghavan K, Smith RL. Predicting effect of food on extent of drug absorption based on physicochemical properties. Pharmaceutical Research. 2007;24:1118-1130
|
|
|
2008
|
48 |
3 |
p. 385-386
|
artikel
|
| 11 |
Letter from the Section Editor
|
|
|
2008
|
48 |
3 |
p. 391-391
|
artikel
|
| 12 |
Malhotra BK, Glue P, Sweeney K, Anziano R, Mancuso J, and Wicker P. Thorough QT study with recommended and supratherapeutic doses of tolterodine. Clinical Pharmacology and Therapeutics. 2007;81:377-385
|
|
|
2008
|
48 |
3 |
p. 386-387
|
artikel
|
| 13 |
Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia
|
Kenney, Christopher
|
|
2008
|
48 |
3 |
p. 379-384
|
artikel
|
| 14 |
Pharmacokinetic and Pharmacodynamic Study of the Concomitant Administration of Methadone and TMC125 in HIV-Negative Volunteers
|
Schöller-Gyüre, Monika
|
|
2008
|
48 |
3 |
p. 322-329
|
artikel
|
| 15 |
Pharmacokinetics of Glucarpidase in Subjects With Normal and Impaired Renal Function
|
Phillips, Marc
|
|
2008
|
48 |
3 |
p. 279-284
|
artikel
|
| 16 |
Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Severe Hepatic Impairment
|
Zimmerman, James J.
|
|
2008
|
48 |
3 |
p. 285-292
|
artikel
|
| 17 |
Population Pharmacokinetics of Cetuximab in Patients With Squamous Cell Carcinoma of the Head and Neck
|
Dirks, Nathanael L.
|
|
2008
|
48 |
3 |
p. 267-278
|
artikel
|
| 18 |
Prevalence of Platelet Nonresponsiveness to Aspirin in Patients Treated for Secondary Stroke Prophylaxis and in Patients With Recurrent Ischemic Events
|
Gengo, Francis M.
|
|
2008
|
48 |
3 |
p. 335-343
|
artikel
|
| 19 |
Ratain MJ, Cohen EE. The value meal: how to save $1700 per month or more on lapatinib. Journal of Clinical Oncology. 2007;25:3397-3398
|
|
|
2008
|
48 |
3 |
p. 388-389
|
artikel
|
| 20 |
Relative Bioavailability of Lisdexamfetamine 70-mg Capsules in Fasted and Fed Healthy Adult Volunteers and in Solution: A Single-Dose, Crossover Pharmacokinetic Study
|
Krishnan, Suma
|
|
2008
|
48 |
3 |
p. 293-302
|
artikel
|
| 21 |
Review/DrugMetabolism and Transport: P-glycoprotein: So Many Ways to Turn It On
|
Callaghan, Richard
|
|
2008
|
48 |
3 |
p. 365-378
|
artikel
|
| 22 |
Review/Methods: Clinical Microdialysis in Skin and Soft Tissues: An Update
|
Schmidt, Stephan
|
|
2008
|
48 |
3 |
p. 351-364
|
artikel
|
| 23 |
Roffey SJ, Obach RS, Gedge JI, Smith DA. What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs. Drug Metabolism Reviews. 2007;39:17-43
|
|
|
2008
|
48 |
3 |
p. 387-387
|
artikel
|
| 24 |
Schachter AD, Ramoni MF. Paediatric drug development. Nature Reviews Drug Discovery. 2007;6:429-430
|
|
|
2008
|
48 |
3 |
p. 388-388
|
artikel
|
| 25 |
TherapeuticReview: The Basis of an Intracrine Pharmacology
|
Re, Richard N.
|
|
2008
|
48 |
3 |
p. 344-350
|
artikel
|
| 26 |
van der Bol JM, Mathijssen RHJ, Loos WJ, et al. Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia. Journal of Clinical Oncology. 2007;25:2719-2726. Commentary by Benowitz NL. Cigarette smoking and the personalization of irinotecan therapy. Journal of Clinical Oncology. 2007;25:2646-2647
|
|
|
2008
|
48 |
3 |
p. 388-388
|
artikel
|
Tijdschrift beschrijving